AU4502797A - Immunological therapy for cancer - Google Patents

Immunological therapy for cancer

Info

Publication number
AU4502797A
AU4502797A AU45027/97A AU4502797A AU4502797A AU 4502797 A AU4502797 A AU 4502797A AU 45027/97 A AU45027/97 A AU 45027/97A AU 4502797 A AU4502797 A AU 4502797A AU 4502797 A AU4502797 A AU 4502797A
Authority
AU
Australia
Prior art keywords
cancer
immunological therapy
immunological
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU45027/97A
Inventor
Baruj Benacerraf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dana Farber Cancer Institute Inc
Original Assignee
Dana Farber Cancer Institute Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dana Farber Cancer Institute Inc filed Critical Dana Farber Cancer Institute Inc
Publication of AU4502797A publication Critical patent/AU4502797A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU45027/97A 1996-10-01 1997-09-26 Immunological therapy for cancer Abandoned AU4502797A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2761696P 1996-10-01 1996-10-01
US60027616 1996-10-01
PCT/US1997/017260 WO1998014207A1 (en) 1996-10-01 1997-09-26 Immunological therapy for cancer

Publications (1)

Publication Number Publication Date
AU4502797A true AU4502797A (en) 1998-04-24

Family

ID=21838759

Family Applications (1)

Application Number Title Priority Date Filing Date
AU45027/97A Abandoned AU4502797A (en) 1996-10-01 1997-09-26 Immunological therapy for cancer

Country Status (2)

Country Link
AU (1) AU4502797A (en)
WO (1) WO1998014207A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10568948B2 (en) 2015-05-13 2020-02-25 Agenus Inc. Vaccines for treatment and prevention of cancer
EP3784688A2 (en) 2018-04-26 2021-03-03 Agenus Inc. Heat shock protein-binding peptide compositions and methods of use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208022A (en) * 1988-05-19 1993-05-04 State University Of New York (Suny) Non-malignant cells coupled to adjuvants and their use in a method to induce anti-tumor immunity
WO1994002167A1 (en) * 1992-07-22 1994-02-03 The Trustees Of Princeton University p53 VACCINE

Also Published As

Publication number Publication date
WO1998014207A1 (en) 1998-04-09

Similar Documents

Publication Publication Date Title
AU1958897A (en) Egf-genistein conjugates for the treatment of cancer
AUPO203996A0 (en) Therapeutic uses
AU4052897A (en) Cancer treatment method
AUPO665397A0 (en) Novel therapy for constipation
AU2916695A (en) Localizer
AU5457096A (en) Gene-transfer-mediated angiogenesis therapy
AU3829895A (en) Methods for treating resistant tumors
AU5005697A (en) Methods of preventing breast cancer
AU4132097A (en) Immune direction therapy
AUPO434196A0 (en) An improved therapeutic
AU4704197A (en) Adjustable reflector
AU7166896A (en) Cancer treatment
GB9509572D0 (en) Cancer therapy
AU8068198A (en) Methods for treating human cancers
AU2547895A (en) Therapeutic phenoxyalkylheterocycles
AU3667297A (en) Therapy for combined hyperlipidemia
AU3860995A (en) Adjusting means
AU4502797A (en) Immunological therapy for cancer
AU4141497A (en) Absorption means
AU3943295A (en) Reflector
AU5330198A (en) Therapeutic compounds
AU2002227270A1 (en) Afterloader apparatus
AU4483597A (en) Novel tumor proteins
AU3978697A (en) Plasmin-depletion therapy
AU1075497A (en) Tumor suppressor